Acuitas: (noun) insight, perception, sharpness.


Acuitas is a biotechnology company that works with partners to develop new therapies to address unmet clinical needs based on our internationally recognized capabilities in delivery technology.


Clinically validated LNP delivery technology

Broad IP portfolio covering LNP delivery of nucleic acid therapeutics

State-of-the-art models to characterize nucleic acid therapeutics

Experienced team to advance products from R&D into clinical development

Excellent communication and project management skills to support our collaboration partners

Acuitas is a private company based in Vancouver, British Columbia and was founded in February 2009. We are partnered with multiple pharmaceutical companies, biotechnology companies and academic institutes to advance nucleic acid therapeutics to the clinic and to the marketplace.

We work with partners and thought-leaders to advance nucleic acid therapeutics into clinical development and commercialization. Our vision is to provide delivery technology that fully enables nucleic acid medicines and thereby address unmet clinical needs.